Sponsor Pipeline

Devalingam Mahalingam Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07042919 Zanzalintinib in Second Line and Beyond for the Treatment of Advanced Liver Cancer Advanced Hepatocellular Carcinoma Recruiting
Disease Areas
Liver Cancer (1)
Get alerts when Devalingam Mahalingam's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free